Cargando…
Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related mortality within the next decade, with limited effective treatment options and a dismal long-term prognosis for patients. Genomic profiling has not yet manifested clinical benefits for diagnosis...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Karger Publishers
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994018/ https://www.ncbi.nlm.nih.gov/pubmed/33451936 http://dx.doi.org/10.1016/j.pan.2020.12.017 |